4-HO-PiPT
Chemical compound
From Wikipedia, the free encyclopedia
4-HO-PiPT, also known as 4-hydroxy-N-propyl-N-isopropyltryptamine or as piprocin, is a substituted tryptamine derivative which is claimed to have psychedelic effects.[1] It has been encountered as a novel designer drug.[2]
Other names4-Hydroxy-N-propyl-N-isopropyltryptamine; Piprocin
| Clinical data | |
|---|---|
| Other names | 4-Hydroxy-N-propyl-N-isopropyltryptamine; Piprocin |
| Routes of administration | Oral |
| Drug class | Non-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C16H24N2O |
| Molar mass | 260.381 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
4-HO-EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[3]
Interactions
Pharmacology
Chemistry
Analogues
Analogues of 4-HO-PiPT include propylisopropyltryptamine (PiPT), 5-MeO-PiPT, 4-HO-MiPT, 4-HO-EiPT, 4-HO-EiBT, 4-HO-DiPT, 4-HO-DsBT, 4-HO-McPT, and 4-HO-McPeT, among others.
History
4-HO-PiPT has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.[2]
Society and culture
Legal status
Canada
4-HO-PiPT is not a controlled substance in Canada as of 2025.[5]